Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination

Cell Adhesion and Migration

Volumn 6, Issue 3, 2012, Pages 179-189

  Payne, Natalie L ^a   Dantanarayana, Ashanti ^a   Sun, Guizhi ^a   Moussa, Leon ^a   Caine, Sally ^a   McDonald, Courtney ^a   Herszfeld, Daniella ^a   Bernard, Claude C A ^a   Siatskas, Christopher ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Experimental autoimmune encephalomyelitis; Gene therapy; Interleukin 4; Mesenchymal stem cell; Multiple sclerosis

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 4; LENTIVIRUS VECTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADIPOSE DERIVED STEM CELL; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ENGINEERING; CELL HOMING; CONTROLLED STUDY; CYTOKINE RESPONSE; DNA MODIFICATION; EARLY INTERVENTION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENE;

EID: 84864917325     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/cam.20341     Document Type: Article

References (70)

1. McQualter JL, Bernard CC. Multiple sclerosis: a battle between destruction and repair. J Neurochem 2007; 100:295-306; PMID:17101032; http://dx.doi.org/10.1111/j.1471-4159.2006.04232.x
2. Payne N, Siatskas C, Barnard A, Bernard CC. The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosis. Curr Stem Cell Res Ther 2011; 6:50-62; PMID:20955155; http://dx.doi.org/10.2174/157488811794480735
3. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 2011; 6:457-78; PMID:21073342; http://dx.doi.org/10.1146/ annurev-pathol-011110-130230
4. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005; 106:1755-61; PMID:15905186; http://dx.doi.org/10.1182/blood-2005-04-1496
5. Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, et al. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J Immunol 2009; 182:5994-6002; PMID:19414750; http://dx.doi.org/10.4049/jimmunol.0803962
6. Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009; 57:1192-203; PMID:19191336; http://dx.doi.org/10.1002/glia.20841
7. Lanza C, Morando S, Voci A, Canesi L, Principato MC, Serpero LD, et al. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J Neurochem 2009; 110:1674-84; PMID:19619133; http://dx.doi.org/10.1111/j.1471-4159.2009.06268.x
8. Zhang J, Li Y, Lu M, Cui Y, Chen J, Noffsinger L, et al. Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice. J Neurosci Res 2006; 84:587-95; PMID:16773650; http://dx.doi.org/10.1002/ jnr.20962
9. Gerdoni E, Gallo B, Casazza S, Musio S, Bonanni I, Pedemonte E, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007; 61:219-27; PMID:17387730; http://dx.doi.org/10.1002/ana.21076
10. Gordon D, Pavlovska G, Uney JB, Wraith DC, Scolding NJ. Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol 2010; 69:1087-95; PMID:20940628; http://dx.doi.org/10.1097/NEN. 0b013e3181f97392
11. Imitola J, Chitnis T, Khoury SJ. Cytokines in multiple sclerosis: from bench to bedside. Pharmacol Ther 2005; 106:163-77; PMID:15866318; http://dx.doi.org/10.1016/j.pharmthera.2004.11.007
12. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol 2012; 24:1-6; PMID:22277983
13. Siatskas C, Chan J, Field J, Murphy K, Nasa Z, Toh BH, et al. Gene therapy strategies towards immune tolerance to treat the autoimmune diseases. Curr Gene Ther 2006; 6:45-58; PMID:16475945; http://dx.doi.org/10.2174/ 156652306775515600
14. Paul WE, Zhu J. How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 2010; 10:225-35; PMID:20336151; http://dx.doi.org/10. 1038/nri2735
15. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133-41; PMID:16200068; http://dx.doi.org/10.1038/ni1261
16. Zhu J, Davidson TS, Wei G, Jankovic D, Cui K, Schones DE, et al. Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 2009; 206:329-41; PMID:19188499; http://dx.doi.org/10.1084/jem.20081666
17. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003; 3:721-32; PMID:12949496; http://dx.doi.org/10.1038/nri1181
18. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3:23-35; PMID:12511873; http://dx.doi.org/10.1038/nri978
19. Butti E, Bergami A, Recchia A, Brambilla E, Del Carro U, Amadio S, et al. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther 2008; 15:504-15; PMID:18239607; http://dx.doi.org/10.1038/gt.2008.10
20. Pace L, Pioli C, Doria G. IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression. J Immunol 2005; 174:7645-53; PMID:15944265
21. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176:1355-64; PMID:1383385; http://dx.doi.org/10.1084/jem.176.5.1355
22. Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol 1998; 161:4437-46; PMID:9780223
23. Falcone M, Rajan AJ, Bloom BR, Brosnan CF. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J Immunol 1998; 160:4822-30; PMID:9590229
24. Ponomarev ED, Maresz K, Tan Y, Dittel BN. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007; 27:10714-21; PMID:17913905; http://dx.doi.org/10.1523/JNEUROSCI.1922-07.2007
25. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994; 180:1961-6; PMID: 7525845; http://dx.doi.org/10.1084/ jem.180.5.1961
26. Inobe JI, Chen Y, Weiner HL. In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1996; 778:390-2; PMID:8611000; http://dx.doi.org/10.1111/j.1749-6632.1996.tb21153.x
27. Furlan R, Poliani PL, Marconi PC, Bergami A, Ruffini F, Adorini L, et al. Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Ther 2001; 8:13-9; PMID: 11402297; http://dx.doi.org/10.1038/sj.gt.3301357
28. Zhang XY, La Russa VF, Bao L, Kolls J, Schwarzenberger P, Reiser J. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther 2002; 5:555-65; PMID:11991746; http://dx.doi.org/10.1006/mthe.2002.0585
29. Meyerrose TE, Roberts M, Ohlemiller KK, Vogler CA, Wirthlin L, Nolta JA, et al. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells 2008; 26:1713-22; PMID:18436861; http://dx.doi.org/10.1634/stemcells. 2008-0008
30. Manning E, Pham S, Li S, Vazquez-Padron RI, Mathew J, Ruiz P, et al. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 2010; 21:713-27; PMID:20102275; http://dx.doi.org/10.1089/hum.2009.147
31. Min CK, Kim BG, Park G, Cho B, Oh IH. IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39:637-45; PMID:17369865; http://dx.doi.org/10.1038/sj.bmt. 1705644
32. Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 2008; 153:269-76; PMID:18713142; http://dx.doi.org/10. 1111/j.1365-2249.2008.03683.x
33. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315-7; PMID:16923606; http://dx.doi.org/10.1080/14653240600855905
34. Rossi B, Angiari S, Zenaro E, Budui SL, Constantin G. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J Leukoc Biol 2011; 89:539-56; PMID:21169520; http://dx.doi.org/10.1189/jlb.0710432
35. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143-7; PMID:10102814; http://dx.doi.org/10.1126/science.284.5411.143
36. Brooke G, Tong H, Levesque JP, Atkinson K. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 2008; 17:929-40; PMID:18564033; http://dx.doi.org/10.1089/scd.2007.0156
37. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006; 24:1030-41; PMID:16253981; http://dx.doi.org/10.1634/stemcells.2005-0319
38. Ransohoff RM. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009; 31:711-21; PMID: 19836265; http://dx.doi.org/10.1016/j.immuni.2009.09.010
39. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 2003; 197:1073-81; PMID:12732654; http://dx.doi.org/10.1084/jem.20021603
40. Rafei M, Birman E, Forner K, Galipeau J. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol Ther 2009; 17:1799-803; PMID:19602999; http://dx.doi.org/10.1038/mt.2009.157
41. Gordon D, Pavlovska G, Glover CP, Uney JB, Wraith D, Scolding NJ. Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration. Neurosci Lett 2008; 448:71-3; PMID:18950680; http://dx.doi.org/10.1016/j.neulet.2008.10.040
42. Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev 2010; 238:247-62; PMID: 20969597; http://dx.doi.org/10.1111/j.1600-065X.2010.00951.x
43. Goverman J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009; 9:393-407; PMID:19444307; http://dx.doi.org/10.1038/ nri2550
44. Meyer EH, DeKruyff RH, Umetsu DT. T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med 2008; 59:281-92; PMID:17937589; http://dx.doi.org/10.1146/annurev.med.59.061506.154139
45. Aharoni R, Teitelbaum D, Leitner O, Meshorer A, Sela M, Arnon R. Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc Natl Acad Sci U S A 2000; 97:11472-7; PMID: 11027347; http://dx.doi.org/10.1073/pnas.97.21.11472
46. Yang JS, Xu LY, Xiao BG, Hedlund G, Link H. Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats. J Neuroimmunol 2004; 156:3-9; PMID:15465591; http://dx.doi.org/10.1016/j. jneuroim.2004.02.016
47. Petermann F, Korn T. Cytokines and effector T cell subsets causing autoimmune CNS disease. FEBS Lett 2011; 585:3747-57; PMID:21477588; http://dx.doi.org/10.1016/j.febslet.2011.03.064
48. Conlon PJ, Tyler S, Grabstein KH, Morrissey P. Interleukin-4 (B-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals. Biotechnol Ther 1989-1990; 1:31-41; PMID:2562642
49. Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997; 185:1711-4; PMID:9151908; http://dx.doi.org/10.1084/jem.185.9.1711
50. Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP. Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol 2000; 164:3581-90; PMID:10725713
51. Garren H, Ruiz PJ, Watkins TA, Fontoura P, Nguyen LT, Estline ER, et al. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity 2001; 15:15-22; PMID:11485734; http://dx.doi.org/10.1016/S1074-7613(01)00171-6
52. Furlan R, Poliani PL, Galbiati F, Bergami A, Grimaldi LM, Comi G, et al. Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Hum Gene Ther 1998; 9:2605-17; PMID:9853527; http://dx.doi.org/10.1089/hum.1998.9.17-2605
53. Poliani PL, Brok H, Furlan R, Ruffini F, Bergami A, Desina G, et al. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Hum Gene Ther 2001; 12:905-20; PMID:11387056; http://dx.doi.org/10.1089/104303401750195872
54. Payne N, Siatskas C, Bernard CC. The promise of stem cell and regenerative therapies for multiple sclerosis. J Autoimmun 2008; 31:288-94; PMID:18504116; http://dx.doi.org/10.1016/j.jaut.2008.04.002
55. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005; 195:16-26; PMID:15904921; http://dx.doi.org/10.1016/j. expneurol.2005.03.018
56. Constantin G, Marconi S, Rossi B, Angiari S, Calderan L, Anghileri E, et al. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009; 27:2624-35; PMID:19676124; http://dx.doi.org/10.1002/stem.194
57. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008; 3:e2213; PMID:18493317; http://dx.doi.org/10.1371/ journal.pone.0002213
58. Sarugaser R, Hanoun L, Keating A, Stanford WL, Davies JE. Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One 2009; 4:e6498; PMID:19652709; http://dx.doi.org/10.1371/ journal.pone.0006498
59. Rice CM, Scolding NJ. Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination. Cell Adh Migr 2010; 4:235-40; PMID:20234187; http://dx.doi.org/10.4161/cam.4.2.11404
60. Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 2007; 25:220-7; PMID:16960135; http://dx.doi.org/10.1634/stemcells.2006-0243
61. Kim JH, Park DJ, Yun JC, Jung MH, Yeo HD, Kim HJ, et al. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 2012; 302:F1141-50; PMID:22205231; http://dx.doi.org/10.1152/ajprenal.00060.2011
62. Kim JM, Lee ST, Chu K, Jung KH, Song EC, Kim SJ, et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007; 1183: 43-50; PMID:17920570; http://dx.doi.org/10.1016/j.brainres.2007.09.005
63. Ohashi PS. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat Rev Immunol 2002; 2:427-38; PMID:12093009
64. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145:3796-806; PMID:2147202
65. Howard M, Harada N. Interleukin-4 (IL-4). In: Nicola, NA, ed. Guidebook to cytokines and their receptors. Oxford: Oxford University Press, 1994:44-46.
66. Dutta R, Trapp BD. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 2011; 93:1-12; PMID:20946934; http://dx.doi.org/10.1016/j.pneurobio.2010.09.005
67. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005; 106:4057-65; PMID:16118325; http://dx.doi.org/10. 1182/blood-2005-03-1004
68. Chan WK, Lau AS, Li JC, Law HK, Lau YL, Chan GC. MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-gamma challenge. Exp Hematol 2008; 36:1545-55; PMID: 18715686; http://dx.doi.org/10. 1016/j.exphem.2008.06.008
69. Karnezis T, Mandemakers W, McQualter JL, Zheng B, Ho PP, Jordan KA, et al. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci 2004; 7:736-44; PMID: 15184901; http://dx.doi.org/ 10.1038/nn1261
70. Slavin A, Ewing C, Liu J, Ichikawa M, Slavin J, Bernard CC. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 1998; 28: 109-20; PMID:9771980; http://dx.doi.org/10.3109/08916939809003872